Archives for June 27, 2018

← 2018

First product derived from cannabis given US FDA nod

By Ben Hargreaves

UK-based GW Pharmaceuticals has been given marketing approval by the US FDA for its product, Epidiolex, to be used for the treatment of two severe forms of epilepsy – Lennox-Gastaut syndrome and Dravet syndrome.